Imitation and development

The Gritpharma has a unique strategy on generic drug development, It is our characteristic to develop characteristic generic drugs according to the consistency evaluation idea and provide high-quality process technology and services for downstream pharmaceutical companies. At the same time, using high-level research and development strength and national policies to encourage research and innovation of the spring, according to MAH policy dividends, independent development of special generic drugs, to strive for the domestic first imitation or the first three listings, grab the market opportunity. We are committed to becoming an innovative pharmaceutical company with light assets, high technology and new business models!